Naqi Logix Inc. has taken a significant step in its financial strategy by extending convertible promissory notes to key executives. This move, announced in a recent filing, is aimed at securing additional capital for the company.
The extension of the notes, originally set to mature on October 31, 2026, has been approved for an additional year, now set to expire on October 31, 2027. This decision was made by the Board of Directors and involves two executives: Mark Godsy and Sandeep Arya.
Background
Naqi Logix Inc. operates within the services sector, specifically focusing on computer programming and data processing, as indicated by its SIC classification of 7370. The company is based in Vancouver, British Columbia, and has been actively filing various forms with the SEC, including recent submissions on October 22 and October 16, 2026.
What the Filing Says
According to the filing dated November 2, 2026, the company stated, "The Extension Agreements for the convertible promissory notes for both Mark Godsy in the amount of $318,959.38 and Sandeep Arya in the amount of $150,000 have been approved by the Board of Directors of the Company to be extended for one year, with the new expiry date of October 31, 2027." This extension maintains all other terms and conditions as they were.
Impact
This financial maneuver may have implications for Naqi Logix’s operational capabilities and its strategic initiatives moving forward. By extending these notes, the company is not only securing necessary funds but also demonstrating confidence in its leadership team. This could influence other firms in the computer programming and data processing industry to consider similar financing strategies.
What's Next
The filing does not specify what happens next regarding the company’s financial plans or any further actions that may be taken following this extension.
For more details, the filing can be accessed through the SEC under accession number 0001213900-26-114651.
Read Next
Pozavarovalnica Sava files 13F Notice for Q3 2026
Broad Peak Investment Advisers reveals $465M portfolio in filing
AGUR Provident files 13F-HR with $4.4 million in holdings
PLDT Inc. changes external auditor amid governance shift
Tiziana Life Sciences Reports Positive Phase 2a Trial Results
Can-Fite BioPharma Secures Eurasian Patent for Piclidenoson









